Login to Your Account



NewCo News: Tube Pharmaceuticals Raises Seed Finance for Tubulysins

By Cormac Sheridan


Tuesday, August 9, 2011
The intellectual property surrounding a certain class of cancer molecules has found a new home in Tube Pharmaceuticals GmbH, a Vienna-based start-up, which recently closed a seed funding round of €1 million (US$1.4 million).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription